Skip to main content
. Author manuscript; available in PMC: 2022 Jan 15.
Published in final edited form as: Arch Biochem Biophys. 2020 Dec 1;697:108702. doi: 10.1016/j.abb.2020.108702

Figure 3. Structure basis of brain penetrating KMO inhibitors.

Figure 3.

The interaction between compound 1 and Pseudomonas fluorescens KMO [30] (Structure file acquired from Protein Data Bank, 6FP1, https://www.rcsb.org). Key active site residues are shown in atom coloured sticks, carbons of KMO in blue, inhibitor 1 in cyan and FAD in yellow.